Search to Find a Background Report

Next Steps: Find a result that matches whom you're looking for the most. Once you find a match, click "Search For Background Reports" to continue. Or use the form below to find the person you are searching for.

USsearch Dog

Here are your results!

Please enter a first name
Please enter a last name

By clicking “SEARCH” I agree to the current USSearch TERMS OF USE and PRIVACY POLICY, and agree not use the products or services of USSearch to determine one's eligibility for credit, housing, insurance, employment or any other reason subject to the Fair Credit Reporting Act (“FCRA”). I further understand that USSearch is not a “consumer reporting agency” and does not provide “consumer reports” under the FCRA.

Mark Roby

We have 14 records for Mark Roby in Rhode Island, ranging in age from 43 years old to 81 years old. Mark has been found in 4 cities including East Greenwich, Exeter, Saunderstown, Warwick. On file we have 37 email addresses. And 42 phone numbers linked to Mark in Rhode Island, with area codes such as 203, 208, 219, 239 and 248, and 17 other area codes. The information below may also include images, social media accounts and more.

Name

Mark Roby

Age

75

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • joan b roby
  • joan m roby
  • mark randall roby
  • mark s roby
  • mark sinclair roby
  • mary s roby
  • roby randall joan
  • mr mark s roby
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 680832090@facebook
  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (203) 980-9287
  • (401) 398-8145
  • (860) 663-2545
  • (316) 634-2055
  • (603) 292-6349
  • (860) 429-5262
  • (315) 735-8351
  • (860) 227-2942
  • (941) 351-3189

Associated Email Addresses

  • xxxxx@collegeclub.com
  • xxxxxx@go.com
  • xxxxxx@yahoo.com
  • xxxxxx@ymail.com
  • xxxxxxx@aol.com
  • xxxxxxx@gmail.com
  • xxxxxxxx@amoco.com
  • xxxxxxxx@flash.net
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@gateway.net
  • xxxxxxxxx@gmail.com
  • xxxxxxxxx@igateway.net
  • xxxxxxxxx@tycohealthcare.com
  • xxxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxxx@msn.com
  • xxxxxxxxxxxxxx@gmail.com

Last Known Phone Numbers

(203) 980-9287 (Primary Phone)

mobile

cellco partnership dba verizon wireless - ct (verizon wireless)

(401) 398-8145

landline

comcast ip phone llc

First Reported June 01, 2011

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

185 Randall Ave
Warwick, Rhode Island 02889

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 60 Deep Meadow Ln
    East Greenwich, Rhode Island 02818
  • 150 Glover Ave
    Norwalk, Connecticut 06850
  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 11 Grace St
    Hartford, Connecticut 06106

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

What Could You Find in a Background Report?

  • Possible Aliases
  • Possible Relatives
  • Associated Phone Numbers
  • Possible Last Known Phone Numbers
  • Possible User IDs
  • Approximate Age Range
  • Possible Educations
  • Associated Email Addresses
  • Possible Job History
  • Possible Past Addresses
  • Possible Jobs
  • Possible Last Known Address
  • Associated Addresses
  • Possible Asset History

SEARCH FOR BACKGROUND REPORTS

Name

Mark Roby

Age

52

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mr marcus r roby
  • mr mark a roby
  • mr mark ronald roby
  • mr mark s roby
  • mr roby ronald joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 680832090@facebook
  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin
  • 5/388/9a6@linkedin
  • 15857550@linkedin
  • #9a63885@linkedin
  • 107469585119948077244@google

Associated Phone Numbers

  • (219) 218-5668
  • (219) 629-4525
  • (219) 742-8092
  • (414) 342-6170

Associated Email Addresses

  • xxxxxx@go.com
  • xxxxxx@yahoo.com
  • xxxxxxxx@gmail.com
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@gateway.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxx@targetbase.com
  • xxxxxxxxx@tycohealthcare.com
  • xxxxxxxxx@ussurg.com
  • xxxxxxxxx@yahoo.com

Last Known Phone Numbers

(219) 218-5668 (Primary Phone)

mobile

new cingular wireless pcs llc - il (at&t mobility)

First Reported September 21, 2010

(219) 629-4525

mobile

new cingular wireless pcs llc - il (at&t mobility)

First Reported June 16, 2010

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)
  • Targetbase Vice President, Business Solutions at Targetbase (since 2018)
  • Targetbase Senior Director, Business Systems & Reporting at Targetbase (2016-2018)
  • Targetbase Senior Director of Business Systems and Reporting at Targetbase (since 2016)
  • Targetbase Director, Business Systems & Reporting at Targetbase (2013-2016)
  • Targetbase Director of Business Systems and Reporting at Targetbase (2013-2016)
  • Targetbase Senior Financial Analyst at Targetbase (2009-2013)
  • Targetbase Financial Analyst at Targetbase (2006-2009)
  • Paragon Project Resources, Inc. Senior Accountant at Paragon Project Resources, Inc. (2004-2006)
  • Rci Utilities, Inc. Senior Accountant at Rci Utilities, Inc. (2003-2004)
  • Rent-a-center Staff Accountant at Rent-a-center (2002-2003)
  • Loloi Rugs
  • Loloi Rugs
  • Loloi Rugs
  • Joon Loloi
  • Joon Loloi
  • Targetbase
  • Targetbase
  • Targetbase
  • Targetbase
  • Targetbase
  • Paragon Project Resources, Inc.
  • Rci Utilities, Inc.
  • Rent-a-center

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut
  • Bachelor of Business Administration (bba), Finance from Texas Christian University - M.j. Neeley School of Business (1998-2002)
  • Highland Park High School (1994-1998)

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 3804 Erie Ct Apt 1
    East Chicago, Indiana 46312
  • 3804 Erie Ct
    East Chicago, Indiana 46312
  • 2664 Madison St
    Gary, Indiana 46407
  • 150 Glover Ave
    Norwalk, Connecticut 06850

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Director of Business Systems and Reporting

    Targetbase

  • Mark Roby
    Director, Business Systems & Reporting

    Targetbase

  • Mark Roby
    Financial Analyst

    Targetbase

  • Mark Roby
    Senior Accountant

    Paragon Project Resources, Inc.

  • Mark Roby
    Senior Accountant

    Rci Utilities, Inc.

  • Mark Roby
    Senior Director of Business Systems and Reporting

    Targetbase

  • Mark Roby
    Senior Director, Business Systems & Reporting

    Targetbase

  • Mark Roby
    Senior Financial Analyst

    Targetbase

  • Mark Roby
    Senior Vice President of Information Technology

    Joon Loloi

  • Mark Roby
    Senior Vice President of Information Technology

    Loloi Rugs

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Staff Accountant

    Rent-a-center

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vice President of Information Technology

    Joon Loloi

  • Mark Roby
    Vice President of Information Technology

    Loloi Rugs

  • Mark Roby
    Vice President, Business Solutions

    Targetbase

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

43

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • marcus lee roby
  • mark roby
  • mark l roby
  • mark lee roby
  • roby joan
  • mr mark s roby
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 680832090@facebook
  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (813) 317-3602
  • (248) 546-6882
  • (860) 663-2545
  • (941) 351-3189
  • (941) 756-8753
  • (575) 551-4265

Associated Email Addresses

  • xxxxxx@go.com
  • xxxxxx@verizon.net
  • xxxxxx@yahoo.com
  • xxxxxxx@gmail.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@gateway.net
  • xxxxxxxxx@hotmail.co.jp
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxx@tycohealthcare.com
  • xxxxxxxxx@ussurg.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxxx@mycity.com

Last Known Phone Numbers

(813) 317-3602 (Primary Phone)

mobile

aerial communications inc (t-mobile)

(248) 546-6882

landline

ameritech michigan (at&t michigan)

First Reported July 26, 2022

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 3102 Tulalip Ave
    Everett, Washington 98201
  • 4931 79th Avenue Dr E
    Sarasota, Florida 34243
  • 1585 W Martintown Rd
    North Augusta, South Carolina 29860
  • 150 Glover Ave
    Norwalk, Connecticut 06850

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

71

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mr mark s roby
  • mr roby s joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 680832090@facebook
  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (860) 663-2545
  • (401) 398-8145
  • (203) 980-9287
  • (941) 351-3189
  • (603) 292-6349

Associated Email Addresses

  • xxxxxx@yahoo.com
  • xxxxxxx@gmail.com
  • xxxxxxxx@amoco.com
  • xxxxxxxx@flash.net
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxxxx@gmail.com

Last Known Phone Numbers

(860) 663-2545 (Primary Phone)

landline

southern new england telephone company dba frontier communications of connecticut (frontier)

First Reported June 03, 2001

(401) 398-8145

landline

comcast ip phone llc

First Reported April 22, 2011

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 113 Wehrli Rd
    Long Valley, New Jersey 07853
  • 150 Glover Ave
    Norwalk, Connecticut 06850
  • 11 Grace St
    Hartford, Connecticut 06106

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

64

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mr mark m roby
  • mr mark r roby
  • mr mark randall roby
  • mr mark s roby
  • mr mark sinclair roby
  • mr roby s joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 680832090@facebook
  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (860) 663-2545
  • (405) 771-4355
  • (603) 292-6349
  • (405) 775-3350
  • (401) 398-8145
  • (405) 431-7100
  • (405) 431-7101
  • (719) 596-4699
  • (941) 351-3189

Associated Email Addresses

  • xxxxxx@go.com
  • xxxxxx@yahoo.com
  • xxxxxx@ymail.com
  • xxxxxxx@gmail.com
  • xxxxxxxx@amoco.com
  • xxxxxxxx@flash.net
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@gateway.net
  • xxxxxxxxx@gmail.com
  • xxxxxxxxx@igateway.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxx@tycohealthcare.com
  • xxxxxxxxxxx@yahoo.com
  • xxxxxxxxxxxxx@msn.com

Last Known Phone Numbers

(860) 663-2545 (Primary Phone)

landline

southern new england telephone company dba frontier communications of connecticut (frontier)

First Reported June 19, 2014

(405) 771-4355

landline

southwestern bell telephone company (at&t southwest)

First Reported April 18, 2011

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 3124 N Douglas Blvd
    Spencer, Oklahoma 73084
  • 35 Kimball Way
    Newmarket, New Hampshire 03857
  • 8947 Ne 51st St
    Spencer, Oklahoma 73084
  • 150 Glover Ave
    Norwalk, Connecticut 06850

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

76

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • marc b roby
  • marc brian roby
  • mark a roby
  • mark b roby
  • mark brian roby
  • mark s roby
  • roby brian joan
  • mr mark s roby
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 680832090@facebook
  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (248) 546-6882
  • (860) 663-2545
  • (636) 677-0253
  • (401) 398-8145
  • (603) 292-6349
  • (941) 351-3189
  • (941) 756-8753
  • (203) 980-9287
  • (248) 298-9213
  • (248) 515-6911
  • (314) 550-5170

Associated Email Addresses

  • xxxxxx@yahoo.com
  • xxxxxx@ymail.com
  • xxxxxxx@aol.com
  • xxxxxxx@gmail.com
  • xxxxxxxx@amoco.com
  • xxxxxxxx@flash.net
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@gmail.com
  • xxxxxxxxx@igateway.net
  • xxxxxxxxx@tycohealthcare.com
  • xxxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxx@hotmail.com
  • xxxxxxxxxxxxx@msn.com
  • xxxxxxxxxxxxxx@gmail.com

Last Known Phone Numbers

(248) 546-6882 (Primary Phone)

landline

ameritech michigan (at&t michigan)

First Reported May 01, 2000

(860) 663-2545

landline

southern new england telephone company dba frontier communications of connecticut (frontier)

First Reported June 19, 2014

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 25430 Karen St
    Oak Park, Michigan 48237
  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 150 Glover Ave
    Norwalk, Connecticut 06850
  • 11 Grace St
    Hartford, Connecticut 06106

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Principal

    Neomend/davol

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

71

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • joanne l roby
  • joanne louise roby
  • mark louise roby
  • roby louise joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (315) 735-8351
  • (315) 338-0448
  • (860) 227-2942
  • (860) 663-2545

Associated Email Addresses

  • xxxxxx@yahoo.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxxx@mycity.com

Last Known Phone Numbers

(315) 735-8351 (Primary Phone)

landline

verizon new york inc

First Reported December 04, 2000

(315) 338-0448

landline

verizon new york inc

First Reported October 02, 2015

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 1069 Trackside Dr Apt 6
    Marcy, New York 13403
  • 8700 Front Beach Rd Unit 5304
    Panama City Beach, Florida 32407
  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 9821 Ridgecrest Dr
    Hillsboro, Missouri 63050

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

71

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • joan m roby
  • mark m roby
  • roby m joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (203) 980-9287
  • (401) 398-8145
  • (860) 663-2545
  • (315) 735-8351
  • (860) 227-2942

Associated Email Addresses

  • xxxxx@collegeclub.com
  • xxxxxx@yahoo.com
  • xxxxxxx@aol.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@amoco.com
  • xxxxxxxx@flash.net
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxx@mycity.com

Last Known Phone Numbers

(203) 980-9287 (Primary Phone)

mobile

cellco partnership dba verizon wireless - ct (verizon wireless)

(401) 398-8145

landline

comcast ip phone llc

First Reported September 01, 2018

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

185 Randall Ave
Warwick, Rhode Island 02889

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 60 Deep Meadow Ln
    East Greenwich, Rhode Island 02818
  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 9821 Ridgecrest Dr
    Hillsboro, Missouri 63050

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

49

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mark a roby
  • mark alan roby
  • roby alan joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (636) 789-2240
  • (636) 797-5871
  • (248) 546-6882
  • (636) 677-7628
  • (636) 677-0253
  • (314) 550-5170
  • (314) 603-9820
  • (314) 677-0253
  • (636) 262-3320

Associated Email Addresses

  • xxxxxx@yahoo.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxxx@gmail.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxx@mycity.com
  • xxxxxxxxxxxxxxxx@gmail.com

Last Known Phone Numbers

(636) 789-2240 (Primary Phone)

landline

southwestern bell telephone company (at&t southwest)

First Reported February 25, 2004

(636) 797-5871

landline

southwestern bell telephone company (at&t southwest)

First Reported February 25, 2004

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 9821 Ridgecrest Dr
    Hillsboro, Missouri 63050
  • 3136 Crystal Circle Dr
    High Ridge, Missouri 63049
  • 5500 Country Ln
    High Ridge, Missouri 63049
  • 11 Grace Ln
    Killingworth, Connecticut 06419

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Principal

    Neomend/davol

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

76

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • joan m roby
  • mark m roby
  • roby m joan
  • ms joan m roby

Possible Relatives

Possible User IDs

  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (860) 663-2545
  • (401) 398-8145
  • (636) 677-0253
  • (203) 980-9287

Associated Email Addresses

  • xxxxx@collegeclub.com
  • xxxxxx@yahoo.com
  • xxxxxxx@aol.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@amoco.com
  • xxxxxxxx@flash.net
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxx@mycity.com

Last Known Phone Numbers

(860) 663-2545 (Primary Phone)

landline

southern new england telephone company dba frontier communications of connecticut (frontier)

First Reported October 05, 2000

(401) 398-8145

landline

comcast ip phone llc

First Reported April 22, 2011

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 3136 Crystal Circle Dr
    High Ridge, Missouri 63049
  • 9821 Ridgecrest Dr
    Hillsboro, Missouri 63050

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • ms joan m roby
  • ms mark m roby
  • ms roby m joan

Possible Relatives

Possible User IDs

  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (636) 789-2240
  • (636) 797-5871
  • (636) 677-7628

Associated Email Addresses

  • xxxxxx@yahoo.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxxx@gmail.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxx@aol.com
  • xxxxxxxxxxxx@mycity.com

Last Known Phone Numbers

(636) 789-2240 (Primary Phone)

landline

southwestern bell telephone l.p. (at&t southwest)

(636) 797-5871

landline

southwestern bell telephone l.p. (at&t southwest)

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 9821 Ridgecrest Dr
    Hillsboro, Missouri 63050
  • 11 Grace Ln
    Killingworth, Connecticut 06419

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Principal

    Neomend/davol

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

49

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mark a roby
  • roby a joan
  • ms joan m roby

Possible User IDs

  • 4/219/753@linkedin
  • 12478959@linkedin
  • #7532194@linkedin

Associated Phone Numbers

  • (314) 677-0253
  • (636) 677-7628

Associated Email Addresses

  • xxxxxx@yahoo.com
  • xxxxxxx@hotmail.com
  • xxxxxxxx@yahoo.com
  • xxxxxxxxx@att.net
  • xxxxxxxxx@frontiernet.net
  • xxxxxxxxx@salientsurgical.com
  • xxxxxxxxxx@gmail.com
  • xxxxxxxxxx@lavabit.com
  • xxxxxxxxxxxx@mycity.com

Last Known Phone Numbers

(314) 677-0253 (Primary Phone)

mobile

t-mobile usa inc

(636) 677-7628

landline

southwestern bell telephone company (at&t southwest)

Jobs

  • Neomend/davol Vp/site Leader at Neomend/davol (since 2012)
  • Davol (division of Bard) - Surgical Specialties Division Vp/site Leader at Davol (division of Bard) - Surgical Specialties Division (2012-2016)
  • Cr Bard Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control at Cr Bard (2011-2012)
  • Cr Bard Sr. Director / R&d, Clinical Affairs at Cr Bard (2010-2012)
  • Cr Bard Sr. Director, Tissue Regeneration R&d and Clinical Affairs at Cr Bard (2010-2011)
  • Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) Vice President / R&d at Salient Surgical Technologies, Inc.(startup Acquired by Medtronic) (2008-2010)
  • Salient Surgical Technologies Vp / R&d at Salient Surgical Technologies (2008-2010)
  • Promethean Surgical Chief Operating Officer at Promethean Surgical (2006-2008)
  • U.s. Surgical / Covidien Vp / Marketing at U.s. Surgical / Covidien (2005-2006)
  • U.s. Surgical / Covidien Vp / Suture-biosurgery R&d at U.s. Surgical / Covidien (2001-2002)
  • Us Surgical / Covidien Vp / R&d at Us Surgical / Covidien (2001-2005)
  • U.s. Surgical / Covidien Sr. Director / Suture R&d at U.s. Surgical / Covidien (1999-2001)
  • Medtronic Site Manager at Medtronic (1998-1999)
  • Tyco / United States Surgical Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing at Tyco / United States Surgical (1995-1997)

Education

  • Mba from Nasson College
  • Bachelor of Applied Science (b.a.sc.), Chemistry from University of Connecticut
  • Ph.d., Polymer Chemistry from the University of Connecticut

Last Known Address

60 Deep Meadow Ln
East Greenwich, Rhode Island 02818

Kent

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 11 Grace Ln
    Killingworth, Connecticut 06419
  • 9821 Ridgecrest Dr
    Hillsboro, Missouri 63050

Job History

  • Mark Roby
    Chief Operating Officer

    Promethean Surgical

  • Mark Roby
    Principal

    Neomend/davol

  • Mark Roby
    Site Manager

    Medtronic

  • Mark Roby
    Sr. Director / Pre-clinical, Clinical Affairs, Quality Design Control

    Cr Bard

  • Mark Roby
    Sr. Director / R&d, Clinical Affairs

    Cr Bard

  • Mark Roby
    Sr. Director / Suture R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Sr. Director, Advanced Materials / Sr. Director, R&d and Manufacturing

    Tyco / United States Surgical

  • Mark Roby
    Sr. Director, Tissue Regeneration R&d and Clinical Affairs

    Cr Bard

  • Mark Roby
    Vice President / R&d

    Salient Surgical Technologies, Inc.(startup Acquired by Medtronic)

  • Mark Roby
    Vp / Marketing

    U.s. Surgical / Covidien

  • Mark Roby
    Vp / R&d

    Salient Surgical Technologies

  • Mark Roby
    Vp / R&d

    Us Surgical / Covidien

  • Mark Roby
    Vp / Suture-biosurgery R&d

    U.s. Surgical / Covidien

  • Mark Roby
    Vp/site Leader

    Davol (division of Bard) - Surgical Specialties Division

  • Mark Roby
    Vp/site Leader

    Neomend/davol

Name

Mark Roby

Age

81

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mark j roby
  • mark s robt
  • mark s roby
  • mark sidney roby

Possible Relatives

Associated Phone Numbers

  • (401) 294-2043
  • (401) 295-7528
  • (239) 209-7176
  • (609) 987-0012
  • (239) 731-0640
  • (609) 295-7528

Associated Email Addresses

  • xxxxx@frontiernet.net

Last Known Phone Numbers

(401) 294-2043 (Primary Phone)

landline

verizon new england inc (verizon communications)

(401) 295-7528

landline

verizon new england inc (verizon communications)

First Reported March 01, 2013

Last Known Address

155 Yawgoo Valley Rd Apt 9e
Exeter, Rhode Island 02822

Washington

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 155 Yawgoo Valley Rd
    Exeter, Rhode Island 02822
  • 1032 Ne 2nd Ter
    Cape Coral, Florida 33909
  • 101 Lassen Ct Apt 1
    Princeton, New Jersey 08540
  • 3642 Long Iron Ct
    North Fort Myers, Florida 33917
Name

Mark Roby

Age

81

AKA (Aliases, nicknames, alternate spellings, married and/or maiden names):

  • mark j roby
  • mark s robt
  • mark s roby
  • mark sidney roby

Possible Relatives

Associated Phone Numbers

  • (239) 209-7176
  • (239) 278-1264
  • (239) 731-0640
  • (401) 294-2043
  • (401) 295-7528
  • (609) 987-0012
  • (908) 698-1983
  • (208) 229-6275
  • (609) 295-7528

Associated Email Addresses

  • xxxxx@frontiernet.net
  • xxxxxx@aol.com
  • xxxxxx@yahoo.com
  • xxxxxxx@frontiernet.net
  • xxxxxxxxxx@gmail.com
  • xxxxxxxxxxx@gmail.com
  • xxxxxxxxxxxx@hotmail.com

Last Known Phone Numbers

(239) 209-7176 (Primary Phone)

mobile

new cingular wireless pcs llc - ga (at&t mobility)

First Reported August 13, 2010

(239) 278-1264

landline

centurylink of florida inc (united)

First Reported July 26, 2016

Last Known Address

Po Box 383
Saunderstown, Rhode Island 02874

Washington

Past Addresses

Homes, rental properties, businesses, apartments, condos and/or other real estate associated with Mark Roby.

  • 155 Yawgoo Valley Rd Apt 4f
    Exeter, Rhode Island 02822
  • 155 Yawgoo Valley Rd
    Exeter, Rhode Island 02822
  • 3642 Long Iron Ct
    North Fort Myers, Florida 33917
  • 101 Lassen Ct Apt 1
    Princeton, New Jersey 08540

Top People with the Same Last Name

Click here to search for background reports.

SEARCH

Public Records Available!

Click here to search public records.

SEARCH

Questions & Answers

How old is Mark S Roby?

Mark S Roby is possibly 75 years old and maybe was born in October 1950.

Where does Mark S Roby live?

Mark S Roby has been associated with 7 addresses, the last known one is 185 Randall Ave, Warwick, Ri 02889-6510.

What is Mark S Roby’s phone number?

Mark S Roby has been known to have 14 phone numbers, including (203) 980-9287.

What is Mark S Roby’s email address?

Mark S Roby has been known to have 23 email addresses, including xxxxxx@yahoo.com.

Who is Mark S Roby related to?

Mark S Roby's possible relatives include Catherine M Roby, Chris Mark Roby, Janet Melissa Roby and others.

What does Mark S Roby do for a living?

Mark S Roby could be a Vp/site Leader at Neomend/davol and might have 13 other jobs on file.

Did Mark S Roby go to school?

Mark S Roby could of attended Nasson College where Mark S Roby received a degree in Mba.

Does Mark S Roby have professional licenses?

Mark S Roby could have a professional license, including an expired accountant license in NJ

Select the first letter of either the first or last name of the person you are searching for.

Search by First Name

Search by Last Name